NRGene’s Initial Public Offering

Herzog Fox & Neeman advised NRGene on the deal.

NRGene completed an Initial Public Offering on the Tel Aviv Stock Exchange this week and raised NIS 100 million.

NRGene develops artificial intelligence solutions that analyze genomics big data to enhance plants’ and animals’ natural breeding processes without genetic engineering. NRGene has already partnered with several leading global companies from 30 countries.

The Herzog Fox & Neeman team was led by partners Eyal Bar-Zvi (Picture), Efrat Tzur, associates Elina Shechter, Eilon Morag and Ofek Galipoliti.

Involved fees earner: Eyal Bar-Zvi – Herzog Fox & Neeman; Ofek Galipoliti – Herzog Fox & Neeman; Eilon Morag – Herzog Fox & Neeman; Elina Shechter – Herzog Fox & Neeman; Efrat Tzur – Herzog Fox & Neeman;

Law Firms: Herzog Fox & Neeman;

Clients: NRGene ;


Author: Michael Patrini.